Collaborative Journalism Senate Scrutiny Intensifies: The Battle Over Keytruda, Patent "Gimmicks," and the Future of Cancer Care June 30, 2026 Ammar Sabilarrohman In a significant escalation of congressional oversight regarding the pharmaceutical industry’s pricing strategies, U.S. Senator Maggie Hassan (D-N.H.) has launched a pointed inquiry into Merck & Co., demanding accountability for…
